MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA Users
Status:
Unknown status
Trial end date:
2021-04-30
Target enrollment:
Participant gender:
Summary
This multicenter, double-blind, Randomized, parallel-group study in subjects with
methamphetamine dependence was to assess the efficacy of MBRP combined with vortioxetine and
MBRP alone on 24-week abstinence rates, improvement of cognition and depressive symptoms.
Phase:
Phase 4
Details
Lead Sponsor:
Central South University Sir Run Run Shaw Hospital
Collaborators:
Huazhong University of Science and Technology Shenzhen Mental Health Center